Related references
Note: Only part of the references are listed.Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence
Jonathan L. Robbins et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2021)
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone
Denis Antoine et al.
AMERICAN JOURNAL ON ADDICTIONS (2021)
Buprenorphine-naloxone microdosing: an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market
Privia A. Randhawa et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study
Jonathan Callan et al.
JOURNAL OF ADDICTION MEDICINE (2020)
Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting
Joao P. De Aquino et al.
JOURNAL OF ADDICTION MEDICINE (2020)
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review
Phillip S. Kim et al.
CURRENT PAIN AND HEADACHE REPORTS (2020)
Case Reports or Case-Series: Intravenous buprenorphine micro-dosing induction in a patient on methadone treatment: a case report.
Kelly Crane et al.
PSYCHOSOMATICS (2020)
Effectiveness of micro-induction approaches to buprenorphine initiation: A systematic review protocol
Jessica Moe et al.
ADDICTIVE BEHAVIORS (2020)
Transitioning From Intrathecal Hydromorphone to Sublingual Buprenorphine-Naloxone Through Microdosing: A Case Report
Isaiah T. Crum et al.
A & A PRACTICE (2020)
Case Series: Limited Opioid Withdrawal With Use of Transdermal Buprenorphine to Bridge to Sublingual Buprenorphine in Hospitalized Patients
Victor M. Tang et al.
AMERICAN JOURNAL ON ADDICTIONS (2020)
A Case Report: Rapid Micro-Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended-Release in an Adolescent With Severe Opioid Use Disorder
Pouya Azar et al.
AMERICAN JOURNAL ON ADDICTIONS (2020)
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case series
Rupinder Brar et al.
DRUG AND ALCOHOL REVIEW (2020)
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Jennifer Rozylo et al.
ADDICTION SCIENCE & CLINICAL PRACTICE (2020)
Rapid Induction of Buprenorphine/Naloxone for Chronic Pain Using a Microdosing Regimen: A Case Report
Danny S. Lee et al.
A & A PRACTICE (2020)
Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach
Mackenzie Duncan Gregory Caulfield et al.
BMJ CASE REPORTS (2020)
Management of opioid use disorder in the USA: present status and future directions
Carlos Blanco et al.
LANCET (2019)
Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol
Dale Terasaki et al.
PHARMACOTHERAPY (2019)
Buprenorphine Induction Without Opioid Withdrawal
Amer Raheemullah et al.
AMERICAN JOURNAL OF THERAPEUTICS (2019)
Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series
Sukhpreet Klaire et al.
AMERICAN JOURNAL ON ADDICTIONS (2019)
A Review of Novel Methods To Support The Transition From Methadone and Other Full Agonist Opioids To Buprenorphine/Naloxone Sublingual In Both Community and Acute Care Settings
Sumantra Monty Ghosh et al.
CANADIAN JOURNAL OF ADDICTION (2019)
Everything is not right anymore: Buprenorphine experiences in an era of illicit fentanyl
Sydney M. Silverstein et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2019)
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
Marc R. Larochelle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Endogenous and Exogenous Opioids in Pain
Gregory Corder et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 41 (2018)
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Patil Armenian et al.
NEUROPHARMACOLOGY (2018)
Developing an opioid use disorder treatment cascade: A review of quality measures
Arthur Robin Williams et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Drug Binding Poses Relate Structure with Efficacy in the μ Opioid Receptor
Katy J. Sutcliffe et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics
Cullen L. Schmid et al.
CELL (2017)
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone
Erin Kelty et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation
Catherine M. Cahill et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Retention in medication-assisted treatment for opiate dependence: A systematic review
Christine Timko et al.
JOURNAL OF ADDICTIVE DISEASES (2016)
Long-Term Course of Opioid Addiction
Yih-Ing Hser et al.
HARVARD REVIEW OF PSYCHIATRY (2015)
Transdermal Buprenorphine, Opioid Rotation to Sublingual Buprenorphine, and the Avoidance of Precipitated Withdrawal
Howard Kornfeld et al.
AMERICAN JOURNAL OF THERAPEUTICS (2013)
Opioid Withdrawal Syndrome: Emerging Concepts and Novel Therapeutic Targets
Ashish K. Rehni et al.
CNS & Neurological Disorders-Drug Targets (2013)
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010
Louisa Degenhardt et al.
LANCET (2013)
Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons
Vu C. Dang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Basic opioid pharmacology: an update
Hasan Pathan et al.
BRITISH JOURNAL OF PAIN (2012)
Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
Donna A. Volpe et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Transdermal Buprenorphine to Switch Patients from Higher Dose Methadone to Buprenorphine without Severe Withdrawal Symptoms
Melanie Hess et al.
AMERICAN JOURNAL ON ADDICTIONS (2011)
Factors associated with complicated buprenorphine inductions
Susan D. Whitley et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Comparing overdose mortality associated with methadone and buprenorphine treatment
James R. Bell et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine
Hans G. Kress
EUROPEAN JOURNAL OF PAIN (2009)
Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization
Michael S. Virk et al.
JOURNAL OF NEUROSCIENCE (2009)
Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated μ-opioid receptor-Gs coupling
Tally M. Largent-Milnes et al.
JOURNAL OF PAIN (2008)
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100 mg of daily methadone
James Rosado et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users
F Termorshuizen et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
The National Treatment Outcome research study (NTORS): 4-5 year follow-up results
M Gossop et al.
ADDICTION (2003)
Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers
MK Greenwald et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Changes in methadone treatment practices - Results from a national panel study, 1988-2000
T D'Aunno et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
A 33-year follow-up of narcotics addicts
YI Hser et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Mice deficient for δ- and γ-opioid receptors exhibit opposing alterations of emotional responses
D Filliol et al.
NATURE GENETICS (2000)
Share Paper
